What antibiotics are recommended for Group B streptococcus (GBS) colonization in pregnant women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotics for Group B Streptococcus in Pregnancy

For pregnant women colonized with Group B streptococcus (GBS), intravenous penicillin G is the first-line antibiotic for intrapartum prophylaxis, with specific alternatives for women with penicillin allergies based on their risk of anaphylaxis. 1

First-Line Antibiotic Regimens

Non-Allergic Patients

  • Penicillin G: 5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until delivery 1
    • Preferred due to narrow spectrum (less likely to select for resistant organisms)
  • Alternative: Ampicillin, 2 g IV initial dose, then 1 g IV every 4 hours until delivery 1

Management of Penicillin-Allergic Patients

Low Risk for Anaphylaxis

  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours until delivery 1
    • For patients without history of anaphylaxis, angioedema, respiratory distress, or urticaria following penicillin/cephalosporin administration

High Risk for Anaphylaxis

Patients with history of anaphylaxis, angioedema, respiratory distress, or urticaria following penicillin/cephalosporin administration:

  1. If GBS isolate is susceptible to clindamycin and erythromycin:

    • Clindamycin: 900 mg IV every 8 hours until delivery 1
  2. If GBS isolate is resistant to erythromycin but susceptible to clindamycin:

    • Clindamycin may be used only if testing for inducible clindamycin resistance is negative 1
  3. If GBS isolate is resistant to clindamycin, shows inducible resistance, or susceptibility is unknown:

    • Vancomycin: 1 g IV every 12 hours until delivery 1

Important Clinical Considerations

Antimicrobial Susceptibility Testing

  • For penicillin-allergic women at high risk for anaphylaxis, antimicrobial susceptibility testing of GBS isolates is essential 1
  • Clinicians must specifically request this testing when submitting specimens 1

Key Changes from Previous Guidelines

  • Erythromycin is no longer an acceptable alternative for GBS prophylaxis in penicillin-allergic women 1
  • The definition of high risk for anaphylaxis has been clarified as history of anaphylaxis, angioedema, respiratory distress, or urticaria following administration of penicillin/cephalosporin 1

Timing of Antibiotic Administration

  • Intrapartum antibiotic prophylaxis is optimal if administered for at least 4 hours before delivery 1
  • Obstetric procedures should be timed accordingly when possible, but medically necessary procedures should not be delayed solely to achieve 4 hours of prophylaxis 1

Pitfalls to Avoid

  • Do not use oral antibiotics to treat GBS colonization during pregnancy as this is ineffective in eliminating carriage or preventing neonatal disease 1
  • Do not delay medically necessary obstetric procedures solely to achieve 4 hours of GBS prophylaxis 1
  • Do not use erythromycin for GBS prophylaxis as it is no longer considered acceptable 1
  • Do not administer vancomycin as first-line therapy; reserve it for penicillin-allergic women at high risk for anaphylaxis when clindamycin cannot be used 1
  • Do not forget to request antimicrobial susceptibility testing when collecting specimens from penicillin-allergic patients 1

Special Considerations

  • Vancomycin should be used with caution in patients with renal impairment and when administered with other potentially nephrotoxic drugs 2
  • For women receiving antibiotics for suspected chorioamnionitis, additional GBS-specific prophylaxis is not needed if the regimen includes agents active against streptococci 1

By following these evidence-based recommendations, the risk of early-onset GBS disease in newborns can be significantly reduced while minimizing adverse effects of antibiotic therapy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.